Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spencer T Martin

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Connecticut Medicine|December 4, 2015
New Options in Insulin TherapyNidhi Saraiya, Spencer T Martin
Pharmacotherapy|April 1, 2011
Belatacept: a novel biologic for maintenance immunosuppression after renal transplantationSpencer T Martin, Eric M Tichy, Steven Gabardi
The Annals of Pharmacotherapy|January 12, 2012
Influenza in solid organ transplant recipientsSpencer T Martin, Mina J Torabi, Steven Gabardi
Pharmacotherapy|April 23, 2014
Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment optionsMiae Kim, Spencer T Martin, Keri R Townsend, et al.
Pharmacotherapy|February 20, 2016
Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant RecipientHeather L Kutzler, Xiaoyi Ye, Caroline Rochon, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2011
Induction immunosuppressive therapies in renal transplantationSteven Gabardi, Spencer T Martin, Keri L Roberts, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2013
Risk of posttransplant lymphoproliferative disorder associated with use of belataceptSpencer T Martin, Jaclyn T Powell, Monank Patel, et al.
Transplantation Proceedings|November 23, 2019
Compound Effect of Kidney Donor Profile Index and Cold Ischemic Time on 1-Year Kidney Transplant Recipient OutcomesHeather L Kutzler, Spencer T Martin, David M O'Sullivan, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 27, 2015
Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipientsMonika Zmarlicka, Spencer T Martin, Sophia M Cardwell, et al.
Journal of the American Medical Informatics Association : JAMIA|July 21, 2012
Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient populationRuchi Tiwari, Demetra S Tsapepas, Jaclyn T Powell, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Connecticut Medicine|December 4, 2015
New Options in Insulin TherapyNidhi Saraiya, Spencer T Martin
Pharmacotherapy|April 1, 2011
Belatacept: a novel biologic for maintenance immunosuppression after renal transplantationSpencer T Martin, Eric M Tichy, Steven Gabardi
The Annals of Pharmacotherapy|January 12, 2012
Influenza in solid organ transplant recipientsSpencer T Martin, Mina J Torabi, Steven Gabardi
Pharmacotherapy|April 23, 2014
Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment optionsMiae Kim, Spencer T Martin, Keri R Townsend, et al.
Pharmacotherapy|February 20, 2016
Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant RecipientHeather L Kutzler, Xiaoyi Ye, Caroline Rochon, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2011
Induction immunosuppressive therapies in renal transplantationSteven Gabardi, Spencer T Martin, Keri L Roberts, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2013
Risk of posttransplant lymphoproliferative disorder associated with use of belataceptSpencer T Martin, Jaclyn T Powell, Monank Patel, et al.
Transplantation Proceedings|November 23, 2019
Compound Effect of Kidney Donor Profile Index and Cold Ischemic Time on 1-Year Kidney Transplant Recipient OutcomesHeather L Kutzler, Spencer T Martin, David M O'Sullivan, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 27, 2015
Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipientsMonika Zmarlicka, Spencer T Martin, Sophia M Cardwell, et al.
Journal of the American Medical Informatics Association : JAMIA|July 21, 2012
Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient populationRuchi Tiwari, Demetra S Tsapepas, Jaclyn T Powell, et al.
Pageof 3